2m 2m 2m 2m 2m 2m 2m
iShs Biotechnology (IBB)
NASDAQ
$208.61+$0.86 (+0.42%)
Price as of Oct 26, 2026 4:23 PM EDT- 34.16%1-Year Change
iShs Biotechnology (IBB)
$208.61+$0.86 (+0.42%)
- 233Holdings Count
- $10.8BTotal Assets
- 50.88%Top 10 Percentage
Holdings
Holding | Latest Close | Shares Held | Weight %
| Market Value |
|---|---|---|---|---|
GILDGilead Sciences | $156.04 | 5.9M | 8.56% | $926.8M |
AMGNAmgen | $439.26 | 2.0M | 8.29% | $897.2M |
VRTXVertex Pharma | $523.93 | 1.6M | 7.83% | $847.6M |
REGNRegeneron Pharma | $805.02 | 756,317 | 5.72% | $619.5M |
MRNAMODERNA | $200.10 | 2.8M | 5.22% | $564.9M |
NTRANatera | $403.95 | 1.0M | 3.81% | $412.4M |
ARGXarGEN-X SpADR | $873.71 | 424,146 | 3.43% | $371.5M |
ILMNIllumina | $269.42 | 1.1M | 2.86% | $309.6M |
BIIBBiogen | $250.69 | 1.1M | 2.62% | $284.1M |
$186.99 | 1.5M | 2.55% | $276.1M | |
ONCBeOne Medi Sp ADR | $377.63 | 642,065 | 2.27% | $245.4M |
ALNYAlnylam Pharma | $224.03 | 1.0M | 2.14% | $231.4M |
$587.50 | 316,394 | 1.71% | $185.0M | |
INCYIncyte | $115.71 | 1.5M | 1.66% | $179.3M |
GMABGENMAB SP ADR | $43.79 | 4.2M | 1.56% | $169.1M |
INSMInsmed | $93.39 | 1.6M | 1.44% | $156.1M |
ROIVROIVANT SCIENCES | $36.49 | 4.0M | 1.38% | $149.8M |
CRLCharles Riv Lab | $345.37 | 360,305 | 1.13% | $122.4M |
EXELExelixis | $64.53 | 1.8M | 1.10% | $119.6M |
ASNDASCENDIS PHARMA BR | $243.37 | 470,567 | 1.06% | $114.3M |
MEDPMedpace Holdings | $669.20 | 171,501 | 1.04% | $112.2M |
NBIXNeurocrine Biosc | $142.70 | 766,959 | 1.01% | $109.9M |
HALOHalozyme Therape | $125.63 | 856,977 | 0.99% | $106.7M |
BBIOBRIDGEBIO PHARMA | $68.56 | 1.3M | 0.84% | $91.1M |
TECHBio-Techne | $72.55 | 1.2M | 0.80% | $86.4M |
BMRNBiomarin Pharm | $55.95 | 1.5M | 0.76% | $82.6M |
MDGLMadrigal Pharmct | $434.24 | 164,219 | 0.69% | $74.4M |
RGENRepligen | $176.93 | 406,750 | 0.67% | $72.7M |
$60.43 | 1.1M | 0.64% | $69.7M | |
TWSTTWIST BIOSCIENCE | $139.92 | 486,604 | 0.61% | $65.9M |
Holdings by Sector
- Healthcare100.00%